These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17056095)

  • 1. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.
    Hasebe T; Okada N; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Tsuda H; Kinoshita T
    Hum Pathol; 2010 May; 41(5):706-15. PubMed ID: 20060154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosis.
    Miyata Y; Kanda S; Ohba K; Nomata K; Eguchi J; Hayashida Y; Kanetake H
    J Urol; 2006 Jul; 176(1):348-53. PubMed ID: 16753442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor vascular invasion in breast carcinoma. Hematoxylin-eosin versus immunohistochemical staining for factor VIII antigen].
    Obermair A; Czerwenka K; Kurz C; Kaider A; Sevelda P
    Dtsch Med Wochenschr; 1994 Nov; 119(44):1491-6. PubMed ID: 7525176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast: a prospective study.
    Hasebe T; Sasaki S; Imoto S; Ochiai A
    Mod Pathol; 2002 Sep; 15(9):904-13. PubMed ID: 12218207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased detection of lymphatic vessel invasion by D2-40 (podoplanin) in early breast cancer: possible influence on patient selection for accelerated partial breast irradiation.
    Debald M; Pölcher M; Flucke U; Walgenbach-Brünagel G; Walgenbach KJ; Höller T; Wolfgarten M; Rudlowski C; Büttner R; Schild H; Kuhn W; Braun M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1128-33. PubMed ID: 20133078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lymphovascular invasion in vulvar cancer by D2-40 (podoplanin) as a predictor for inguinal lymph node metastases.
    Braun M; Wardelmann E; Debald M; Walgenbach-Bruenagel G; Höller T; Wolfgarten M; Sauerwald A; Rudlowski C; Büttner R; Kuhn W; Pölcher M
    Onkologie; 2009 Dec; 32(12):732-8. PubMed ID: 20016234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphatic infiltration identified by D2-40 monoclonal antibody predicts lymph node metastasis in submucosal invasive colorectal cancer.
    Kawaura K; Fujii S; Murata Y; Hasebe T; Ishii G; Itoh T; Sano Y; Saito N; Ochiai A
    Pathobiology; 2007; 74(6):328-35. PubMed ID: 18087197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
    Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
    Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessel invasion detected by the D2-40 monoclonal antibody is an independent prognostic factor in node-negative esophageal squamous cell carcinoma.
    Imamura Y; Watanabe M; Nagai Y; Baba Y; Hirashima K; Karashima R; Iwatsuki M; Yoshida N; Kinoshita K; Kurashige J; Iyama K; Baba H
    J Surg Oncol; 2012 Mar; 105(3):277-83. PubMed ID: 22271500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
    J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.